Approval · Notice of Compliance 18270 · 2016
ENTOCORT: Notice of Compliance 18270
Issued July 13, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18270
- Date
- July 13, 2016
- Company
- Tillotts Pharma GmbhRheinfelden, Baden-Wuerttemberg, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTOCORT | 02229293 | Marketed |
| ENTOCORT ENEMA | 02052431 | Marketed |
Medicinal ingredients
- BUDESONIDE 3 MG per CAP
- BUDESONIDE 2.3 MG per TAB
- SODIUM CHLORIDE 115 ML per KIT